Builders FirstSource BLDR
Basic Materials · Construction Materials · Synthos Deep Dive · 2026-07-03
The Overview
Builders FirstSource is the biggest company that sells lumber, roof trusses, wall panels, windows and doors to the contractors who build houses. When lots of homes are being built, it makes a lot of money; when housing slows down — like right now, with high mortgage rates — its sales and profits fall. Last quarter it actually lost money for the first time in years.
Is the stock cheap or expensive? On today's depressed earnings it looks pricey, but on what it normally earns in a healthier housing market it's cheap — you're paying roughly 14× next year's expected profit and getting a ~9% free-cash-flow yield. The catch is you're buying during the storm and betting the sun comes back.
Our verdict is Watch — a good company at a fair-to-cheap price, but the timing is uncertain and there's real debt, so it's one to keep an eye on rather than back the truck up on today.
Here's what our three scores mean in everyday terms:
- Downside Risk 6/10 (above average). It's inexpensive and throws off cash, but it carries meaningful debt and its stock swings hard — it already fell about 60% from its high.
- Growth Quality 4/10 (below average). The "growth" analysts pencil in is really the business recovering from a bad patch, not a company steadily getting bigger every year.
- Exponential Potential 3/10 (low). This is a mature distributor of building materials. It can do well when housing turns up, but it is not the kind of business that multiplies many times over.
The one big worry: if high mortgage rates keep homebuilding depressed for longer than expected, both profits and the company's debt burden get worse before they get better.
Putting a number on it: our fair-value estimate is $93 against a current price of $67.72 — real upside if our numbers are right.
Our summary metrics
Cheap on forward EPS & 9% FCF yield, but net-debt/EBITDA ~4.3× at trough, beta 1.42 and a −60% peak drawdown make it a high-cyclical.
Forward EPS "growth" is cyclical recovery off a trough (Q1'26 was a loss), not secular compounding; ROIC ~5.6%, margins compressing.
A mature building-products distributor in a housing downcycle — big TAM but no acceleration; the story is mean-reversion, not exponential.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
A mature building-products distributor in a housing downcycle — big TAM but no acceleration; the story is mean-reversion, not exponential.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $106.38 (high $143 / low $81; 22 Buy · 20 Hold · 1 Sell) — context, not our anchor |
| Valuation | 32× depressed TTM EPS · ~20× FY26E · ~14× FY27E · ~10× FY29E · EV/S 0.97× · EV/EBITDA 11.8× · FCF yield ~9.5% |
| Technicals | Downtrend — $84.69, −43% off the 52-wk high, below the 200-DMA, −33% 12-mo (SPY +21%); RSI 59 |
| Conviction | Low — 0 expert voices in the Synthos KB; call rests entirely on the numbers |
| Position sizing | Watch-list / small tactical only, ≤1–2% if you buy the cyclical thesis |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for BLDR — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $67.72, 10% below the 50-day average ($75), 26% below the 200-day average ($91) — a downtrend. 55% below the 52-week high of $149, 3% above the 52-week low of $66.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $67.72 is currently inside the band (band $66–$77).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 42.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.26, negative momentum.
Relative performance vs S&P 500 & its sector (XLB (sector)), set to 100 a year ago
Solid = BLDR · dashed = S&P 500 · dotted = XLB (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Builders FirstSource (NYSE: BLDR) is the largest US supplier and manufacturer of structural building products, value-added components, and construction services to professional homebuilders, sub-contractors, remodelers, and (to a lesser degree) consumers. Its differentiated, higher-margin products include factory-built roof and floor trusses, wall panels, and stairs (the "manufactured" category), plus vinyl windows, custom millwork/trim, and engineered wood. Headquartered in Irving, TX; ~28,000 employees; founded 1998, IPO 2005. Fiscal year ends December 31. CEO Peter Jackson.
The business is a roll-up: it has grown through hundreds of acquisitions (the 2021 BMC merger was transformational) and has used its scale to consolidate a fragmented industry while returning enormous cash to shareholders via buybacks.
Revenue mix (FY2025, from FMP product segmentation):
- Specialty Building Products & Services — $4.07B (27%)
- Lumber & Lumber Sheet Goods — $3.88B (26%)
- Windows, Doors & Millwork — $3.84B (25%)
- Manufactured Products (trusses, panels — the value-added, margin-rich core) — $3.41B (22%)
By geography: BLDR is a US-only operator. Older FMP geographic segmentation (through 2020) split it into South, West, Southeast, and Northeast regions — the South and West (Sun Belt housing growth markets) are the largest. There is no international exposure and thus no FX risk, but also no geographic diversification away from the US housing cycle.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of BLDR in the Synthos knowledge base. total_claims = 0; zero net-bullish or cautionary voices. None of the tracked expert panel (the investors and operators whose dated claims feed our conviction track) has an on-record, traceable view on this name.
What that means for this note, stated plainly: the verdict is entirely fundamentals- and quant-driven. We are not borrowing anyone's conviction, and we are not manufacturing any. Every number below is either a reported figure (FMP filings), a labeled analyst estimate (FMP consensus), or our own scenario math with assumptions shown. Where the Street has a view we show it as context, not as our anchor.
The relevant outside signal is sell-side: 22 Buy / 20 Hold / 1 Sell (a "Buy" consensus that is really split down the middle), a price-target consensus of $106.38 (high $143, low $81), and an FMP letter rating of B− (overall score 3/5, dinged hardest on debt-to-equity 1/5). We treat all of that as context.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 6 · Above-average | Cheap on forward EPS (~14× FY27E) and a ~9.5% FCF yield cushion the downside, but net-debt/EBITDA has risen to ~4.3× TTM (mgmt's adjusted figure 3.2×) as EBITDA fell, beta is 1.42, and the stock has already had a −60% peak-to-trough drawdown. High-cyclical, not a widow-and-orphan holding. |
| Growth Quality | 4 · Below-average | The forward EPS ramp ($3.89 → $4.28 → $6.21 → $8.35) is cyclical recovery off a trough, not durable secular compounding. FY25 revenue fell 7.4%; Q1'26 was a net loss. ROIC ~5.6%, ROE ~6.9%, gross margin compressing (28.3% in Q1'26 vs 32%+ at the peak). The value-added mix shift and buybacks are the quality offsets. |
| Exponential Potential | 3 · Low | A mature, ~$15B-revenue building-products distributor. Large TAM, but the second derivative is negative right now and the long-run story is share consolidation + housing normalization — good, not exponential. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them. Because BLDR is a cyclical, we anchor on normalized / mid-cycle earnings power and a mid-cycle multiple rather than trough TTM EPS.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Housing starts inflect in late 2026; mortgage rates ease. Value-added mix + buybacks drive FY27E EPS to the high end ~$7.00 and beyond toward ~$8.35 (FY29E). Market pays a cyclical-recovery ~17× on ~$8 normalized EPS. | ~$135 (+59%) |
| Base (our anchor) | Housing stays soft through 2026 then gradually normalizes. FY27E EPS ~$6.21 (consensus). A well-run #1 cyclical earns a mid-cycle ~15× — but on ~$6.2 near-term power, tempered by leverage. | ~$93 (+10%) |
| Bear | Rates stay high, starts fall further; FY26 EPS lands near the low (~$3.7) and FY27 stalls at ~$5. Leverage (~4×+) forces buyback pause; market applies a trough ~11× to ~$5 EPS. | ~$55 (−35%) |
Synthos fair value = the base case, ~$93 (+10%), with the full $55–$135 span as the honest range. Our base sits below the Street's $106 consensus — we discount the cyclical recovery more heavily and weight the rising leverage. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). BLDR is neither right now — it is a cyclical mid-downturn:
- Forward growth is a rebound, not a ramp: revenue actually fell from $16.4B (FY24) to $15.19B (FY25), and consensus has it slipping again to ~$14.8B (FY26E) before recovering to ~$15.6B (FY27E) and ~$17.3B (FY29E). EPS falls from $3.89 (FY25) toward the FY26 trough then recovers. The "growth CAGR" you'd compute off trough EPS is arithmetic, not a secular trend.
- Acceleration (2nd derivative) is negative today. Quarterly revenue: Q1'25 $3.66B → Q4'25 $3.36B → Q1'26 $3.29B (−10.1% YoY). Core organic sales fell 8.3% in Q1'26, with single-family (the biggest driver) down 11.1%. The inflection has not yet arrived.
- Room to run: the US residential building-products TAM is large and fragmented, so BLDR's consolidation runway is real — but at a mature ~$15B revenue base, this is share-gain-plus-cycle, not a demand explosion.
- Reinvestment runway: capital goes disproportionately to buybacks (49.7% of shares retired since 2021) and bolt-on M&A rather than organic capacity growth — a returns-of-capital story, not a reinvest-for-hypergrowth story.
Exponential Potential: Low (3/10). Own BLDR (if at all) for cyclical value + best-in-class share consolidation + aggressive buybacks, not for exponential growth. The honest framing is that this is a Watch-tier cyclical, not a Degen-tier compounder.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $15.19B, −7.4% (FY24 $16.40B, itself −4% on FY23 $17.10B). The multi-year slide reflects commodity (lumber) deflation and a weak single-family starts environment. Well off the 2022 peak of $22.7B.
- Quarterly trajectory (the downturn is visible): Q1'25 $3.66B → Q2 $4.23B → Q3 $3.94B → Q4 $3.36B → Q1'26 $3.29B (−10.1% YoY). Q1 is seasonally the weakest.
- Margins compressing: gross margin 28.3% in Q1'26 (down 220bp YoY) vs ~32% at the peak; FY25 gross margin 29.0%. TTM EBITDA margin ~8.2%, net margin just 2.0%. Operating leverage works in reverse in a downturn.
- Earnings: FY25 net income $435M (EPS diluted $3.89), down sharply from $1.08B (FY24) and $1.54B (FY23). Q1'26 was a net loss of −$47.4M (−$0.43/sh) — the first loss in years, driven by lower gross profit and higher interest expense.
- Cash flow (the resilient part): FY25 operating CF $1.22B, capex −$363M, FCF $853M (~9.5% FCF yield). Even in a down year the model throws off cash — the counter-cyclical tell (working capital releases as volumes fall). Q1'26 FCF was still positive at $42.7M.
- Balance sheet (the pressure point): net debt ~$5.47B, net-debt/EBITDA ~4.3× TTM (management's adjusted figure was 3.2× at Q1'26, up from 2.0× a year earlier). Long-term debt $4.97B. Leverage rises mechanically as EBITDA falls — the single number to watch.
6. Valuation — priced in or room?
On trough TTM earnings BLDR looks expensive (32× P/E) — but that is the classic cyclical trap of valuing a down-cycle on depressed EPS. The right lens is forward / normalized:
- Forward P/E: ~20× FY26E ($4.28) → ~14× FY27E ($6.21) → ~11× FY28E ($7.31) → ~10× FY29E ($8.35). The multiple compresses fast if the recovery lands.
- Cash & enterprise: EV/EBITDA 11.8×, EV/Sales 0.97×, P/FCF 10.6×, FCF yield ~9.5%, P/B 2.3×. On cash flow it is inexpensive.
- Reverse read: at $84.69 the market is pricing a slow, uncertain housing recovery and some worry about the leverage. If starts normalize, ~$6–8 of EPS at a 14–17× cyclical multiple supports $85–135; if they don't, ~$5 at 11× supports the mid-$50s.
- Street targets (context): consensus $106.38, high $143, low $81; 22 Buy / 20 Hold / 1 Sell — a genuinely split house. Our $93 base is below consensus because we weight the leverage and the still-negative volume trend more heavily.
Not expensive on normalized numbers; the debate is entirely about when volumes turn, not whether the stock is cheap.
7. Technicals (computed from EOD price history)
- Trend: down. $84.69 sits above the 50-DMA ($78.65) but well below the 200-DMA ($100.92) — a death-cross posture (50 below 200). The recent bounce off the 50-DMA has not repaired the primary downtrend.
- Location: −43.2% off the 52-week high ($149.21), +27.6% off the 52-week low ($66.39). The peak-to-trough max drawdown was −59.9% — a violent cyclical de-rating.
- Momentum: RSI(14) 59 — neutral-to-firm, not overbought, not oversold. MACD +2.79 (mildly positive, reflecting the recent bounce).
- Relative strength (the tell): BLDR −33.3% 12-mo vs SPY +20.6% and QQQ +30.3% — massive underperformance. Only over the last 3 months has it stabilized (+4.6% vs SPY +13.7%), still lagging.
- Read: technicals do not yet confirm a bottom — a below-200-DMA cyclical that has stabilized but not broken out. A reclaim of the 200-DMA (~$101) on rising volume would be the technical "housing has turned" tell to wait for.
8. Moat & competitive position
BLDR's edge is scale and density, not a patent or a brand: it is the #1 US supplier to pro homebuilders, with a national footprint, local delivery density, and a growing mix of value-added manufactured components (trusses, panels) that carry higher margins and stickier customer relationships than commodity lumber. Switching costs are moderate (builders value reliable, on-time, on-site delivery and integrated design/manufacturing), and the company's M&A machine keeps consolidating a fragmented industry. It is genuinely well-run. But it is still fundamentally a distributor/manufacturer of building materials exposed to a commoditized end market and the housing cycle — a cost/scale moat, not a pricing-power moat, and gross margin proves it (28–29%, and falling in the downturn).
Peer set (FMP peers, market cap): TopBuild $9.9B (insulation, the closest comp), Carlisle $14.8B, Owens Corning $12.2B, Masco $16.7B, Advanced Drainage Systems $11.7B, Lincoln Electric $14.2B, WESCO $15.0B, Sterling Infrastructure $21.5B, Stantec $8.0B, Huntington Ingalls $11.5B. Most of these carry lower cyclicality and/or richer multiples; BLDR's sub-1× EV/Sales reflects its commodity exposure and thin net margin.
9. Management, capital allocation & guidance
- Capital allocation — the standout: management has been exceptionally aggressive on buybacks, repurchasing 102.6M shares (49.7% of shares outstanding) since August 2021 at an average $81.26 for $8.3B total. On 2026-04-29 the Board authorized up to $500M of new repurchase capacity. No dividend. Buybacks below intrinsic value in a fragmented consolidator can be strongly accretive — but doing them with net-debt/EBITDA at ~4× in a downturn is the aggressive edge of prudent (a bear could call it balance-sheet risk).
- Insider activity: the recent Form 4s are routine — tax-withholding (F-InKind), small gifts, and director stock awards (A-Award) at ~$76, not open-market discretionary selling. No alarming insider signal in the sampled window (through 2026-06-16).
- Management's own guidance (half-weighted — their own book). From the Q1'26 earnings release (SEC 8-K, 2026-04-30), management's 2026 full-year outlook: Net Sales $14.6–15.6B, gross-profit margin 27.5–29%, and Adjusted EBITDA of at least ~$1.1B (the release text is cut off at the low end of the EBITDA range in our capture, so treat the $1.1B as the floor of the guided range, not the midpoint). They also guided $50–70M of productivity savings in 2026 and reiterated "strong cash flow through the cycle." CEO Peter Jackson framed Q1 as "strong strategic share growth in a weak housing market." Read as management's self-interested framing: they are guiding to a soft 2026 and leaning on cost/working-capital discipline and buybacks to compound per-share value while volumes are down.
10. Catalysts & what to watch
- Next earnings: 2026-07-30 (Q2'26; Street EPS $1.32, revenue ~$3.92B). The key lines: core organic sales trend (is the −8% decline moderating?), gross margin (holding the 27.5–29% guide?), and net leverage (is the 3.2–4.3× stabilizing?).
- Housing starts & mortgage rates: the master variable. Single-family starts and the direction of the 30-year mortgage rate drive the whole thesis; a sustained rate decline is the bull trigger.
- Value-added mix: manufactured-products share of revenue — the margin-quality lever management is pulling.
- Buyback pace vs leverage: whether management keeps repurchasing aggressively or throttles back to protect the balance sheet.
- M&A: bolt-on acquisitions (FY25 spent $1.12B on acquisitions) — accretive consolidation vs balance-sheet strain.
Thesis tripwires (what would change the call): two more quarters of worsening core organic declines; gross margin breaking below the 27.5% guide; net-debt/EBITDA pushing above ~4.5× with buybacks continuing; or a reclaim of the 200-DMA on volume (bull tripwire → upgrade candidate).
11. Key risks
- Housing cyclicality (structural to the business model): revenue and margins are levered to single-family starts and mortgage rates; a prolonged high-rate environment keeps earnings depressed. This is the risk.
- Leverage in a downturn: net-debt/EBITDA ~4.3× (adjusted 3.2×) and rising as EBITDA falls; $4.97B long-term debt with interest expense climbing ($74M in Q1'26). A deeper downturn pressures both earnings and the balance sheet simultaneously.
- Commodity (lumber) volatility: lumber deflation has cut ~$4.5B of revenue since 2021; price swings move both the top line and gross margin.
- Aggressive buybacks at high leverage: the capital-return strategy amplifies per-share results in a recovery but adds risk if the downturn extends.
- No expert coverage / low conviction: with 0 KB claims, there is no independent qualitative check on the quant thesis — the call rests entirely on the financials and the housing cycle.
- Thin margins: 2.0% TTM net margin leaves little cushion; small revenue or margin misses swing earnings hard (operating de-leverage).
12. Verdict, position sizing & monitoring
Watch. BLDR is a genuinely good, best-in-class cyclical — #1 share, share-gaining, cash-generative even in a down year, and returning enormous capital via buybacks — trading at a fair-to-cheap ~14× FY27E and a ~9.5% FCF yield. What holds it back from a Buy today is timing and leverage: it is mid-downcycle (FY25 revenue −7.4%, Q1'26 a net loss), volumes are still falling (−8% core organic), net leverage has risen to ~4×, and the technicals remain below the 200-DMA. There is no expert conviction in the KB to lean on. The reward is real if housing turns; the risk is a longer downturn against a levered balance sheet.
- Sizing: Watch-list first. If you buy the cyclical-value thesis, keep it a small tactical position (≤1–2%) and scale in on evidence of a volume/starts inflection rather than committing today. A reclaim of the 200-DMA (~$101) or a moderating organic-sales decline would be the upgrade trigger.
- Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print (next 2026-07-30). This verdict is logged as a tracked Synthos call as of 2026-07-03 at $84.69.
- Single biggest risk: a prolonged housing-starts downturn — every soft quarter worsens both earnings and the ~4.3× leverage at the same time.
Provenance & disclosures
- Traceability: 0 KB claims — BLDR has no expert coverage in the Synthos knowledge base. This note is explicitly fundamentals- and quant-driven; no conviction is borrowed or fabricated (claim-ID reconciliation is moot because there are no claims to cite).
- Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K dated 2026-04-30. Forward figures are analyst consensus (FMP) or our own labeled scenario math — all estimates.
- Management caveat: the 2026 outlook in §9 is management's own guidance, half-weighted by design (they talk their own book), and our capture truncates the low end of the Adjusted-EBITDA range — treat ~$1.1B as the floor.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").